Skip to content

PEERS Multicenter Osseospeed TM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study

PEERS Multicenter OsseoSpeedTM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study An Open, Prospective Observational Study to Evaluate Implant Stability, Marginal Bone and Soft Tissue Maintenance of the Astra Tech Dental Implant System: OsseoSpeedTM TX Profile Implant in Patients With Tooth Loss in the Aesthetic Zone or the Posterior Atrophied Mandible

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01400321
Acronym
GAST
Enrollment
300
Registered
2011-07-22
Start date
2011-07-31
Completion date
2014-07-31
Last updated
2012-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inclined Atrophy of the Distal Mandible, Socket Like Atrophy of the Aesthetic Zone

Keywords

dental implant, soft tissue maintenance, bone remodelling, inclined atrophy

Brief summary

The open, prospective, non-controlled observational study is designed to provide information on the short-, medium- and long-term clinical performance of the Astra Tech OsseospeedTM implant surface in combination with a special implant design. The study will provide information on implant survival and soft tissue and bone maintenance as clinical performance of the OsseoSpeedTM TX Profile Implant in the aesthetic zone or the posterior mandible with socket like atrophy.

Detailed description

Within the new OsseoSpeedTM TX Profile Implant from Astra Tech a special surface modification treated with diluted hydrofluoric acid is combined with an inclined implant-abutment interface to support soft tissue and marginal bone maintenance in the aesthetic zone or the socket like atrophy in the mandible. Pre-clinical studies of the OsseospeedTM modification support improvement in osseointegration. Both aspects are of special clinical interest in critical situations e.g. reduced bone quantity and quality or in case of socket atrophy with loss of the papillae. The outcome variables of interest are implant survival and the marginal bone and soft tissue response for clinical evaluation of the OsseoSpeedTM TX Profile Implant from Astra Tech. In contrast to the original treatment protocol with a healing period of 3 and 6 months for maxilla and mandible, respectively, the healing period is reduced to 3 months following the recent literature with equal clinical results. Within the present study implants will heal in a transgingival mode and loaded after a healing period of 3 months. For special indications in the aesthetic zone the implants may optionally be loaded following an early loading protocol, which comprehend temporary loading within 48h after implant insertion. Overall implant survival rates are high. However, for implants placed immediately after tooth extraction in the esthetic zone or in the socket like atrophied mandible survival rates are lower. The special physiology of bone resorption in the aesthetic zone exhibit high requirements for soft tissue and bone maintenance for good clinical long term results. Differences in pattern of marginal bone response have been described for different implant systems. The extend of bone loss as also the pattern of remodeling as reaction to OsseospeedTM surface and the special shape of the OsseoSpeedTM TX Profile Implant will be investigated within the present study.

Interventions

None listed

Sponsors

Dentsply Sirona Implants and Consumables
CollaboratorINDUSTRY
Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* loss of tooth aesthetic zone (a maximum of 4 implants) * loss of tooth at the distal mandible (distal canine) (a maximum of 4 implants) * presence of inclined alveolar ridge profile * antagonists are natural teeth or fixed prosthesis

Exclusion criteria

* \< 18 years * Tumour or irradiation * bisphosphonate or cortisone intake * Diabetes mellitus * Mental illness or disorder with affection of compliance * Consumption of \> 20 cigarettes/day * Bruxism * Acute Mucosal infection or illness (e.g. acute Parodontitis, Pemphigus, Lichen) * Relation of Crown to Implant ratio of \> 1 * No clinical primary stability of the implant after insertion

Design outcomes

Primary

MeasureTime frameDescription
Implant survivalafter 24 monthsHow many implants are in situ after an observational period of 24 months (2 years). Data presentation will be a Kaplan Meier Estimate.

Secondary

MeasureTime frameDescription
Marginal bone adaptionafter 24 monthsMarginal bone adaptation will be assessed clinically as probing depth on the lingual aspect of insertion. In addition marginal bone adaption will be followed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant on intraoral radiographs with paralleling technique. Periapical radiographs will be taken pre- and postoperatively at 24 months follow-up visit. A change in marginal bone will be recorded as positive or negative shift compared to the baseline (preoperatively measured bone height).
Pinc aesthetic parameterafter 24 monthsPinc aesthetic score evaluation as previously described by Fürhauser and measurement of width of keratinized mucosa and clinical crone length. Data evaluation will be a negative or positive shift compared to the preoperatively evaluated data.
periodontal parameterafter 24 monthsClinical evaluation of of probing depth in mm (mesial, distal, oral and vestibular), bleeding on probing and Plaque Index as described by Sillness and Löe. Data evaluation will be a negative or positive shift compared to the preoperatively evaluated data.
Detection and description of implant related complications and other adverse and serious adverse eventsover the study period (24 months)Complications are characterized by any failure (mechanical or other) of the implant and/or the prosthetic restoration, as well as the treatment of such failures and will be recorded. The following complications must be reported to the Principal Investigator within 4 working days: * Failed osseointegration * Lost osseointegration * Fixture fracture Adverse events and serious adverse events detection and reporting following GCP-ICH

Countries

Germany

Contacts

Primary ContactWilfried Wagner, MD, DMD, PHD
wilfried.wagner@unimedizin-mainz.de00496131177334
Backup ContactMaximilian Moergel, MD, DMD
maximilian.moergel@unimedizin-mainz.de00496131175459

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026